AngioScore is a clinical stage medical device company based in Alameda, California. AngioScore is the developer and manufacturer of AngioSculpt, a line of innovative coronary angioplasty catheters. An AngioSculpt catheter comprises an angioplasty balloon surrounded by nitinol wires that score arterial lesions as the balloon expands. The potential market encompasses more than half of the 2 million angioplasties performed annually. Intended uses include dilatation prior to delivery of a drug eluting stent, and dilatation of fibrocalcific lesions, in stent restenosis, and small vessels.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 10/09/07 | Series E | 30M | Unknown |
People
Nimrod Tzori (CTO)
Feridun Ozdil (Chief Scientific Officer)
Gary Lazar (Board Member)
Thomas Raffin (Board Member)
Gary Gershony (Chief Medical Officer)
News
AngioScore, balloon-catheter maker, scores $30M
October 9, 2007 9:20 pm
See our story on this Fremont, Calif., medical-device maker in today’s daily briefing at VentureBeat Life Sciences. Continue reading ⟩
Life sciences briefing: Tuesday, Oct. 9, 2007
October 9, 2007 9:03 pm
Featured companies: AngioScore, Forsight Labs, Genoptix, Metastatix, Optherion, QLT UPDATED: See below. Artery opener AngioScore pulls in $30M — AngioScore,… Continue reading ⟩